Home » All » Stock Forecast » abrdn Life Sciences Investors Shares of Beneficial Interest Forecast

abrdn Life Sciences Investors Shares of Beneficial Interest Forecasts for Tomorrow, Week, Month and 5 Years

Updated: April 22 · 2026 at 07:03 UTC

From

▼ -0.39%Market Cap $459.67M · Technical analysis Bearish · Focus area Price + volatility

Forecast Summary

Timeframe	Predicted Price	Past	Historical	Insight
Tomorrow	$17.77 ▼ -0.71%	Yesterday	$17.95 ▲ +0.30%	Tomorrow's abrdn Life Sciences Investors Shares of Beneficial Interest (HQL) setup is anchored to $17.90 and targets $17.77 (-0.71%). The near-term read is downside; watch $18.44 / $17.36 because daily realized volatility is about 3.65%.
Tomorrow's abrdn Life Sciences Investors Shares of Beneficial Interest (HQL) setup is anchored to $17.90 and targets $17.77 (-0.71%). The near-term read is downside; watch $18.44 / $17.36 because daily realized volatility is about 3.65%.
Week	$17.51 ▼ -2.20%	Last Week	$18.07 ▲ +0.92%	The 7-day abrdn Life Sciences Investors Shares of Beneficial Interest model moves from $18.07 to $17.51 (-2.20%). It gives downside momentum context for this stock, so breaks around $18.44 / $17.36 matter more than a single tick.
The 7-day abrdn Life Sciences Investors Shares of Beneficial Interest model moves from $18.07 to $17.51 (-2.20%). It gives downside momentum context for this stock, so breaks around $18.44 / $17.36 matter more than a single tick.
Month	$17.06 ▼ -4.69%	Last Month	$18.25 ▲ +1.97%	The 1-month abrdn Life Sciences Investors Shares of Beneficial Interest target is $17.06 (-4.69%), compared with the live reference near $17.90. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk.
The 1-month abrdn Life Sciences Investors Shares of Beneficial Interest target is $17.06 (-4.69%), compared with the live reference near $17.90. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk.
Year	$16.39 ▼ -8.41%	Last Year	$18.53 ▲ +3.53%	The 1-year abrdn Life Sciences Investors Shares of Beneficial Interest scenario points to $16.39 (-8.41%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates.
The 1-year abrdn Life Sciences Investors Shares of Beneficial Interest scenario points to $16.39 (-8.41%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates.
5 Years	$14.83 ▼ -17.14%	5 Years Ago	$19.19 ▲ +7.20%	The 5-year abrdn Life Sciences Investors Shares of Beneficial Interest view is $14.83 (-17.14%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path.
The 5-year abrdn Life Sciences Investors Shares of Beneficial Interest view is $14.83 (-17.14%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path.

Tomorrow$17.77▼ -0.71%

Yesterday$17.95▲ +0.30%

Tomorrow's abrdn Life Sciences Investors Shares of Beneficial Interest (HQL) setup is anchored to $17.90 and targets $17.77 (-0.71%). The near-term read is downside; watch $18.44 / $17.36 because daily realized volatility is about 3.65%.

Week$17.51▼ -2.20%

Last Week$18.07▲ +0.92%

The 7-day abrdn Life Sciences Investors Shares of Beneficial Interest model moves from $18.07 to $17.51 (-2.20%). It gives downside momentum context for this stock, so breaks around $18.44 / $17.36 matter more than a single tick.

Month$17.06▼ -4.69%

Last Month$18.25▲ +1.97%

The 1-month abrdn Life Sciences Investors Shares of Beneficial Interest target is $17.06 (-4.69%), compared with the live reference near $17.90. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk.

Year$16.39▼ -8.41%

Last Year$18.53▲ +3.53%

The 1-year abrdn Life Sciences Investors Shares of Beneficial Interest scenario points to $16.39 (-8.41%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates.

5 Years$14.83▼ -17.14%

5 Years Ago$19.19▲ +7.20%

The 5-year abrdn Life Sciences Investors Shares of Beneficial Interest view is $14.83 (-17.14%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path.

Risk notice:This forecast is informational only, not financial advice; accuracy depends on volatility, liquidity, macro events, and other external factors.

Price Chart

HistoricalForecastBullishBearish

Technical Analysis

Bearish

Bullish

Neutral

Bearish

Key Indicators

Indicator	Value	Signal
Price	$17.90	Mid
Daily Change	-0.39%	Below
Volatility Cap	20.0%	Mid
Confidence	58%	Below
Data Source	nasdaq-screener	Mid

Historical Data

Current$17.90

Daily Change-0.39%

Market Cap$459.67M

Sourcenasdaq-screener

Current	$17.90	Daily Change	-0.39%
Market Cap	$459.67M	Source	nasdaq-screener

Support & Resistance Levels

$17.36Support 1

$17.90Current

$18.44Resistance 1

Support and resistance are estimated from the trusted current price until deeper historical data is available.

Price Milestones

Key levels & historical context

Current$17.90Live reference price

Used as the anchor for generated forecast calculations.

Next Month$17.06Model projection-4.69%

Directional scenario based on capped drift.

Forecast Accuracy

How our model has performed

58%

Directional

Generated market-data forecast

This page uses live catalog market data and conservative volatility caps. It is informational, not financial advice.

📊

Our algorithm is re-calibrated weekly using the latest price action, volatility regime, and indicator signals. Accuracy varies by timeframe — short-term momentum is more reliable than long-term projections.

Short term

58%

Direction confidence

Long term

Lower

Forecast uncertainty rises with horizon

Investment Scenarios

If you invest $1,000 in HQL today

Bullish Scenario

$18.79

+5.00% from current

Target Price$18.79

ScenarioUpside momentum

Probability50%

Base Scenario

$17.06

-4.69%

Target Price$17.06

ScenarioCapped drift

Probability58%

Bearish Scenario

$17.01

-5.00% from current

Target Price$17.01

ScenarioVolatility drawdown

Probability42%

Basis: Scenario model combines current spot price, recent market direction, and conservative asset-class volatility caps.

Forecast Factors

Market Structure

Price structure reflects the latest momentum regime and support/resistance interaction.

Momentum Bearish · 40/100

24H drift-0.71%

7D drift-2.20%

30D drift-4.69%

Technical Signals

Signals combine RSI, MACD, and moving average stacks to estimate short-term direction.

Mixed — Watching · 50/100

RSIn/a

MACDn/a

MA stackn/a

Macro Context

Rates, dollar strength, and cross-asset risk appetite influence medium-term paths.

Risk-Off Caution · 35/100

1M outlook-4.69%

1Y outlook-8.41%

5Y outlook-17.14%

Frequently Asked Questions

Q What is the abrdn Life Sciences Investors Shares of Beneficial Interest (HQL) forecast for tomorrow?

Using the latest BeCoin market snapshot (April 22 · 2026 at 07:03 UTC), abrdn Life Sciences Investors Shares of Beneficial Interest is projected near $17.77 versus the current reference around $17.90. That implies a modeled move of -0.71% over the next day, with realized prices still sensitive to intraday volatility.

Q What does the 7-day stock outlook suggest for HQL?

The weekly abrdn Life Sciences Investors Shares of Beneficial Interest model points to $17.51, which maps to an expected drift of -2.20% from current conditions. This horizon reacts quickly to momentum shifts, so support/resistance breaks can change the path faster than long-term targets.

Q How should I read the abrdn Life Sciences Investors Shares of Beneficial Interest 1-month and 1-year targets?

The abrdn Life Sciences Investors Shares of Beneficial Interest 1-month target is $17.06 (-4.69%), while the 1-year target is $16.39 (-8.41%). The monthly view tracks prevailing trend pressure, and the yearly view reflects broader cycle assumptions shaped by price momentum, liquidity, and company-specific risk.

Q Why does the abrdn Life Sciences Investors Shares of Beneficial Interest 5-year scenario differ from short-term rows?

The abrdn Life Sciences Investors Shares of Beneficial Interest long-horizon scenario sits near $14.83 with a modeled change of -17.14%. It compounds cycle-continuation assumptions over time, so it should be treated as a scenario envelope rather than a precise endpoint.

Q Where are HQL support and resistance zones right now?

For abrdn Life Sciences Investors Shares of Beneficial Interest, nearest resistance is around $17.36, while nearest support is around $18.44. A clean break above resistance improves continuation odds, while repeated closes under support raise downside risk.

Q How fresh is the abrdn Life Sciences Investors Shares of Beneficial Interest market snapshot?

The displayed stock snapshot is labeled April 22 · 2026 at 07:03 UTC; the latest observed session range is roughly n/a to n/a. These checkpoints are rebuilt from the market feed so the FAQ, milestones, and support/resistance context stay tied to the same data refresh.